Metabolomics as a tool for personalizing medicine: 2012 update

Personalized Medicine
Jinchun SunLaura K Schnackenberg

Abstract

Numerous factors in conjunction with an individual's genetic make up will determine predisposition to disease, adverse or beneficial effects of drug treatment or therapy, and disease progression. A major limitation of current clinical measures is that the disease phenotype, which is comprised of the genotype and other environmental factors, is underestimated. Rather, each disease is treated similarly even though the disease process is highly complex. Methods that evaluate the interaction of genotype and environmental factors would likely be a better indicator of patients' response to medical treatments. The omics technologies, specifically metabolomics, will play a major role in the movement towards personalized medicine. Metabolomics is phenotype driven and should provide better clinical biomarkers. Furthermore, recent studies have shown that associations between genetic variants and downstream metabolite changes can provide a unique description of an individual's genotype and phenotype, which will further enhance the movement towards personalized medicine.

References

Oct 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·L PaulingP Cary
May 1, 1996·Neurobiology of Aging·W E KlunkJ W Pettegrew
Dec 1, 1995·Clinical Pharmacokinetics·R VenkataramananT Starzl
Nov 5, 1997·Annals of the New York Academy of Sciences·J W PettegrewJ A Stanley
Aug 11, 2005·Proceedings of the National Academy of Sciences of the United States of America·Malgorzata MarjanskaMichael Garwood
Sep 28, 2005·Trends in Pharmacological Sciences·Wen-Yue Jiang
Nov 12, 2005·Medicinal Research Reviews·Michael O GlockerHans-Jürgen Thiesen
Apr 21, 2006·Nature·T Andrew ClaytonJeremy K Nicholson
Jul 25, 2006·Neurobiology of Aging·Kejal KantarciClifford R Jack
Jul 25, 2006·The International Journal of Neuroscience·Hisashi KawashimaYasuo Watanabe
Feb 3, 2007·Journal of Proteome Research·Eva Maria Lenz, Ian D Wilson
Apr 25, 2007·NMR in Biomedicine·Ji-Kyung ChoiBruce G Jenkins
Jul 13, 2007·Molecular Systems Biology·Joseph LoscalzoAlbert-Laszlo Barabasi
Aug 19, 2007·Journal of Proteome Research·Aalim M WeljieFrank R Jirik
Oct 24, 2007·Clinical Chemistry·William R WikoffGary Siuzdak
Mar 6, 2008·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Richard D BegerDidier Portilla
Mar 14, 2009·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Justyna E WolakThomas M O'Connell
Apr 9, 2009·Molecular Diagnosis & Therapy·Elizabeth Phillips, Simon Mallal
Apr 29, 2009·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Anders Nordström, Rolf Lewensohn
Aug 12, 2009·Proceedings of the National Academy of Sciences of the United States of America·T Andrew ClaytonJeremy K Nicholson
Aug 27, 2009·Proceedings of the National Academy of Sciences of the United States of America·Ian D Wilson
Sep 29, 2009·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Ulf AnderssonIna Schuppe-Koistinen
Oct 27, 2009·Italian Journal of Pediatrics·Eugenio BaraldiFranco Zacchello
Dec 17, 2009·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Herman van WietmarschenJan van der Greef
Jan 27, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Josep TaberneroFortunato Ciardiello
Feb 26, 2010·Clinical Pharmacology and Therapeutics·J H WinnikeP B Watkins
Apr 23, 2010·Journal of Proteome Research·Joseph L McClayEdwin J C G van den Oord
Apr 29, 2010·Current Atherosclerosis Reports·Kim EkroosReijo Laaksonen
May 7, 2010·Metabolomics : Official Journal of the Metabolomic Society·Rima Kaddurah-DaoukRonald M Krauss
May 19, 2010·Biomarkers in Medicine·Donna L Mendrick, Laura Schnackenberg
Oct 29, 2010·Kidney International·Hyuk Nam KwonSunghyouk Park

❮ Previous
Next ❯

Citations

Feb 16, 2019·Personalized Medicine·Elena E BalashovaAlexander I Archakov
Aug 15, 2018·The Journal of Pharmacology and Experimental Therapeutics·Abubakr MossaLysanne Campeau
Jan 23, 2020·International Journal of Molecular Sciences·Marianna CaterinoIlaria Campesi
Jul 28, 2013·Annals of Clinical Biochemistry·Jeremy R EverettFrancis S Pullen
May 13, 2017·International Journal of Molecular Medicine·Dimitris TsoukalasAristides M Tsatsakis
Sep 1, 2013·Personalized Medicine·Xiaojiao ZhengWei Jia
Nov 13, 2015·Wiley Interdisciplinary Reviews. Systems Biology and Medicine·Mary Regina BolandNicholas P Tatonetti
Aug 8, 2015·Briefings in Bioinformatics·David J Duffy
Sep 1, 2014·Personalized Medicine·Elena López AspirozMaría José García Sánchez
Jan 16, 2021·Cellular and Molecular Life Sciences : CMLS·Insha ZahoorShailendra Giri
Aug 1, 2021·Clinical Chemistry and Laboratory Medicine : CCLM·Ji-Hee HaamYoung-Sang Kim
Jun 14, 2016·Journal of Medicinal Chemistry·Michel FrédérichPascal de Tullio

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Advances in Protein Chemistry and Structural Biology
Nadia KoenDu Toit Loots
Journal of General Internal Medicine
Richard L Kravitz
© 2022 Meta ULC. All rights reserved